Background: Most stroke research is conducted in high income countries, yet most stroke occurs in low-and middleincome countries. There is an urgent need to build stroke research capacity in low-and middle-income countries.
Introduction
In this second paper of a five-paper series on how to do good quality clinical research, we will discuss research in limited resource settings. The Global Burden of Disease investigators estimated that 70% of incident stroke and stroke deaths, half of all prevalent strokes and nearly 80% of DALYs lost were in low-and middle-income countries (LMICs), yet most research is done in high-income countries. 1 However, LMICs have only about 3% equivalent purchasing power to fund this demand. 2 Furthermore, it has been estimated that 90% of medical research is targeted on the health needs of the richest 10% of the world. 3 1 As stroke is occurring at an earlier age in LMICs, there is a disproportionate loss of DALYs in these countries. This has major implications for families, as those with stroke are often the breadwinners of the family, and thus stroke commonly leads to catastrophic financial hardship. 4 The resulting mismatch between burden and research has led to large evidence practice gaps in global health. 5 In addition, there is the inevitable tension in LMICs between cost effective public health strategies to reduce the burden of stroke (such as the identification and treatment of hypertension and stroke unit care), and the attraction of implementing the current ''state of the art'' stroke interventions, such as thrombectomy. There is a risk that piecemeal implementation of aspects of western medicine could consume all the available stroke resources, for very little public health benefit.
High-quality research is needed in LMICs to determine which local solutions work, and what is their costeffectiveness. In this review article, we will discuss the barriers and facilitators of conducting clinical research, provide examples from our own experience, review the literature in this area and provide some new data from our recently completed stroke rehabilitation trial in India.
Methods
We utilized a mixed methods approach of a focused literature search, reflections from our own research careers and insights from a recent Process Evaluation from the ATTEND Trial. 6 Our literature search was performed using the search terms ''stroke'' ''clinical research,'' ''resource poor settings,'' ''developing countries,'' ''low and middle income countries'' to identify relevant articles. This had to be broadened to cover all aspects of health as our initial search failed to reveal stroke specific examples, and experience from other disciplines was likely to be informative.
We supplemented this literature search with some of our findings from our process evaluation of the ATTEND trial which had an aim to identify critical facilitators and barriers in the implementation of a randomized controlled trial (RCT) in India by international research collaboration. 6 The methods of this research have been published in detail previously, 6 but in brief, this involved focus groups and in-depth interviews with thematic analysis of 8 clinical trial coordinating staff, 4 chief investigators, 26 health providers, 22 patients and 22 carers involved in the RCT.
We synthesized the main themes arising from our literature search, our own personal experience, and some of the relevant findings from the ATTEND trial process evaluation (see Box 1).
Results
The main themes identified were manpower and workload, research training, research question and methodology, and research funding.
Manpower and workload
From a survey of the 1312 members of the Indian Academy of Neurology (recorded in January 2015), it was calculated that approximately 935 million people in India had no neurologists working in their geographical area, with only 3% of members recorded to be working in rural areas (covering a further 85 million). 7 India is not unusual in this respect as the World Health Organization reported 0.03 neurologists per 100,000 population in Africa, 0.07 in South-East Asia, against 4.84 in Europe. 8 Neurologists in India (data from 2007) typically cater to 30 to 50 patients a day and approximately 15% of neurologists see more than 50 patients a day. 9 These numbers translate to a private academic institute seeing around 200 neurological patients per day, private clinics seeing 100-150 patients per day, and government institutes seeing 800 patients per day. Demand on neurosurgery is also large with an approximate seven month waiting period for elective neurosurgery at one government hospital in India. 7 These enormous clinical workloads contrast with more manageable numbers seen in high income countries, and thus leave little time for research in LMIC urban areas, and lead to virtually no healthcare provision in many rural areas of the world.
The limited number of trained professionals, and the need to cater to a large number of patients, results in a lack of ''protected time'' for research for neurologists in LMICs, thus limiting their ability to perform good quality research in stroke. In the process evaluation of ATTEND, we found that establishing a supernumerary research team with various roles and responsibilities (e.g. project management, data collection) with on-site training and monitoring according to Good Clinical Practice, was key to facilitating the ''time poor'' neurologists in conducting research, while balancing service delivery.
The lack of research training and relative lack of research funding adds to the challenges.
English et al. 10 have discussed the concept of a Learning Health System that provides an opportunity to conduct pragmatic RCTs, integrated into routine clinical care. 10 However, busy clinicians are only likely to devote a proportion of their time to research if they see the value of such research improving the health of their patients, and presumably providing an interesting and stimulating environment in which to work.
Our experience in trials conducted at Christian Medical College and Hospital Ludhiana might help beginners in establishing a good research environment. The stroke unit at our institute is functional as a multidisciplinary team and was initiated in 2008. A basic observation (by a neuro-physiotherapist of the team) of the common shoulder issues post stroke, led to the formulation of a study on the effects of shoulder taping for shoulder pain and injury post stroke. 11 The team reviewed the literature and designed a low cost, 4-centre RCT to prevent shoulder pain. Another study used an indigenously designed low cost (approx. USD7.7) mirror therapy box to be used for rehabilitation in patients with hemi neglect post stroke. This single center study provided class I evidence that mirror therapy improved hemi neglect in thalamic and parietal lobe strokes. 12 Finally, through an intramural research fund, a 7-center observational study was designed to assess the impact of pre-morbid undernutrition status on short-term stroke outcome. 13 All these studies required an appropriate mentor (see next section, Research Training) and benefited from industry Previously all the research work that I've done, it was all upon me. I am the coordinator, do everything is done, but here it is all structured. So I spend only one hour a week, and so I ask how many patients (the stroke coordinator) has recruited and now I identify patient and tell her, and so it's been really smooth for me, and with all other work that I have to do in the hospital and other research and that has been a great thing from my perspective.''(Neurologist)
Research training
Lack of research training ''There is only a few universities which speak about evidence-based practice, and it is a subject which is not taught at all. . .Many physios don't know how -what evidence means, what evidence-based practice means? They are not aware of it of how evidence works or our trials work or how systematic reviews work? What is the importance of guidelines? What is the importance of clinical pathways, protocols?'' (Physiotherapist) Building of capacity '' I didn't have much idea (about research) at the beginning because after I finished my bachelor's, I just came here. It was a very new experience because I had done my project work in my final year, but that was entirely different than this. My experience with the research was very little so this gave me an opportunity to have better experience and better exposure to research and how to go about things, so it was very good for me to learn. . .and it helped me to boost up my confidence with the patient interaction and how to communicate with them and how to deliver the interventions.'' (ATTEND Stroke coordinator, a physiotherapist) Role of regular communication ''The workshops regularly updating our skills, having a teleconference bi-monthly. It's all great to have such a thing in the trial, as sometimes we may be lost continuing to doing our work. Having such kind of thing is very good and I appreciate the administrative team and the role of people who are involved in this.'' (ATTEND Stroke Coordinator, a physiotherapist) Respect and teamwork ''We want this number of patients to be recruited. Look at the bigger picture. . . So (the principal investigators) have been very inspiring and you know, good messages coming across from all of us in the management team (to the sites) that this is the thing, and we will be presenting your data here. . . They are getting the constant training. . . So it helps. They know that they are being looked into. It isn't that they are on their own. They know that they are being monitored. The monitor is doing the job correctly, monitoring the site. The other people are looking into the monitor's work as well. So it's a coordinated team effort, which has gone into the trial, so it's everybody's efforts.'' (Clinical trial team member 1) Challenges in maintaining the trained workforce ''Actually when ATTEND finishes, we have to see whether there is any other trial we are able to get. Currently at present there is nothing in. Most of the time (for the) really good staff I will find out some study which I will try to continue. (Name withheld) has been for more than four years now, because being somebody who has been with us for sometime, it is very useful because she maintains all our data, all that prospective database, everything she keeps in, and we put in all the forms. . .That made a big difference in our quality of care.'' (Neurologist)
Research question and methodology
Research motivation ''. . .in research we learn new things because the practical knowledge we get in the research, clinical research, we deal with the patients. The main thing is we are serving the patients. We are doing something for the betterment of the patients either directly or indirectly. . .the present patients may not get the benefit of the research but the upcoming patients they will surely get the benefits of the research. . .so they may get that proper treatment in stroke in future.'' (Trial assessor) Improvement in care ''I think this trial was very important, one of the biggest trial I have taken part, and I think I learnt so many things already from conducting this trial here like, for example, like when we teach something for the patient we think that they will follow it strictly, they'll go back and do it, but in many cases it's not so. One, it may be because of the lack of applicability of what we are telling them. Like suppose, for example like we had one patient who was told to do transfer, how to transfer from the bed onto the chair but later we found out the patient doesn't have even a bed at home. . ..So lot of things we found out about our patients which was totally new to us. This was a learning experience.'' (Neurologist) Ethical dilemma ''It is just, that I felt that certain patients, those patients who are in the control have to get certain other things. . . Because after all they are patients also; so we cannot leave that person-that you are on his own if you want to do any physiotherapy or something. '' (Stroke Coordinator) (continued) International Journal of Stroke, 13 (2) support of other commercially sponsored trials run in parallel. This early track record was noticed by local philanthropists, who, in turn provided additional resources to improve the existing stroke care services at the institution, thus further supporting stroke research capacity.
Research training
Research training is essential to achieve high-quality research and reduce research waste. 14 Training can occur locally or internationally and there are established models for both. Local training has the advantage of usually being low cost but will remain challenging due to the competing requirements for clinical service. In cardiovascular medicine, Yusuf 15 has described the local research training by participation in a large-scale international trial during the establishment of the EMERAS (Estudio Multicentrico Estreptoquinisa Republicasde Americ de Sur) collaborative group in South America, that helped build research capacity and led to subsequent projects. The Road traffic Injuries Research Network have reported that seed grants, short-term scholarships, sabbaticals to enable staff from LMICs to work in established highincome country (HIC) units and support to present at international conferences, were successful in building research skills and capacity. 16 In our recent stroke rehabilitation trial in India, international funding allowed 35 full time staff to be employed, and their participation in the trial collaborative meetings, site training visits and participation in national and international stroke conferences provided important opportunities to learn and practice research methods (such as Good Clinical Practice guidelines). 17, 18 Our process evaluation found that respect between members of the Research Funding ''You need to have that ground level experience knowing people from different backgrounds across Indian state lines and to be able to put together something of this magnitude-hundred patients across twelve to fourteen centers is a large number for a country like India where the barriers between states and cultures are so huge. Each state is a country in itself, so to bring them all together is a big challenge and a busy clinician just wouldn't have the time and you know wouldn't be that motivated. . .So, I was glad that someone actually made it happen to have the time invested into it, to have the financial resources come into it, and to have the dedication to find the right staff and to empower them, inspire them through a long period, I mean its three year study. So, that's not easy to do.'' (clinical trial team member 2) Box 2. Case study of funding: The ATTEND trial of family-led rehabilitation for stroke in India.
team and the international collaborators was fundamental for the mutual learning and success of the trial implementation -a finding which has been reported by other research collaborations. 19 Regular communication between the site staff and the clinical coordinating members was highly valued by the clinical research staff on the ground. The cultivated team work approach was a facilitator to trial implementation (e.g. successful patient recruitment and follow-up) which was conducted according to study timelines and within budgeted resources. An illustration of the themes identified is given in Box 1.
While research skills can be learnt during a busy clinical post with appropriate local mentoring and training, a period of research training through scholarships and international training has also proven to increase research capacity. The advantages of an international training scholarship include the opportunity to escape the brutal local clinical workload, with time to concentrate on acquiring research skills. A disadvantage of such a program is that this can lead to a ''brain drain'' if the scholar chooses to stay in the host country! Heimburger et al. 20 have described the success of the Fogarty International Clinical Research Scholars and Fellows Program, demonstrating increasing focus on non-communicable diseases, and a good publication record and excellent subsequent grant success (two-thirds of subsequent grant applications being funded). A more organized and planned research training curriculum is needed in the three year Neurology training and allied health courses in academic institutions across all LMICs. Within LMICs, those with international stroke reputations have an important role in providing local mentorship and being a role model for their institution, and driving change to support a stroke clinician scientist career path in their country.
Research question and methodology
Many of the papers stressed the importance of locally driven research priorities from practitioners and researchers in limited resourced settings in order to truly address the contextual factors and disease burden. [21] [22] [23] [24] [25] Cross-sectional studies of clinical trials compared to global burden of diseases have highlighted the mismatch between disease burden and the number of trials. 24, 25 For example, Condo et al. 23 highlighted that in Rwanda, clinical trials were mainly focused on HIV transmission but that testing of interventions that address the epidemiological transition from infectious diseases to non-communicable diseases, including the significant mental health trauma post genocide were needed. In a paper regarding clinical nephrology research in low resource settings, Anand et al. 22 recommended that high quality epidemiological studies and data registries be a priority in order to highlight local areas of need and channel international funding through research collaborations.
Senior researchers in a panel discussion about nephrology research in resource limited settings advised that broad areas of research questions that align with global interests and still address local needs would be strategic in securing funding. 22 For example, addressing chronic kidney disease as part of the non-communicable disease global burden. Incorporating health systems research within the research question/design to ensure sustainability and exploring issues of ''equal access'' and ''equitable financing,'' e.g. registries to inform gaps, and the collection of relevant data (e.g. health utilization data) would be ideal. 26 Such research evidence addressing broad global interests would also facilitate the ''reverse innovation phenomena'' whereby the research findings from LMIC would be applicable to high income countries. 27 The INTERSTROKE study is a good example of this ''reverse innovation phenomena''. 28 This process of gap analysis and priority setting was reflected in our journey in India -with stroke registries set up at partner sites which helped identify the gap in service delivery and the significance of the research question for an affordable community-based rehabilitation model which was then tested in a RCT. 29 Our process evaluation found that because the research addressed an issue of local priority (the lack of access to multidisciplinary rehabilitation), it was highly motivating for Indian health providers, principal investigators, research staff, patients and carers to participate in the trial. Health providers also described improvements to clinical care, while the trial was conducted, due to the robust data collection and follow-up and greater understanding of the patients' contextual factors. Moreover, an example from the process evaluation of how evidence from high income countries may lack relevance to the local health system context was evident in how a component of our intervention (early supported discharge) was welcomed in concept but not implemented due to the health system issues like bed pressure and affordability of hospitalization. 18 As an example of the ''reverse innovation phenomena'' -in our last investigators' meeting and at the World Stroke Congress, researchers from LMIC (e.g. Uganda, Indonesia) and high income countries (Australia and USA) expressed interest in the task shifting model of rehabilitation, as they thought it would be applicable for their remote populations who also have limited access to stroke rehabilitation.
In LMICs, appropriately trained research staff are a pre-requisite to ensure that research methodology is robust, and not prone to bias. 27 There is increasing
International Journal of Stroke, 13 (2) awareness of research waste, and in a resource-limited environment, it will be essential that research is not wasting precious resources (in both opportunity costs of wasted time and also money). Dandona et al. 30 have summarized a probable strategic framework which would help in improving the quality and number of public health related research in India. Formal training institutes for public health research, exposure, and encouragement towards hands on research experience for medical and paramedical undergraduates and development of performance-based opportunities to public health research scholars for career enhancement can improve the quality of manpower available for research purposes.
In LMICs, collaborative research work has opened many channels for budding professionals to be trained and put their skills to use. Collaborative research work like the ATTEND trial in India 18 ; the Headpost trial in India, Brazil, Chile, Columbia, Taiwan and Sri Lanka 31 ; the RECOVER trial in China
32
; and the ENCHANTED trial in Brazil, China, Columbia, Thailand and Vietnam 33 ; have all used resources from high income countries to recruit patients globally and have established stroke research networks, with resulting high impact studies. Such collaborative research work has enabled resources from rich countries to be used in LMICs in the employment of research staff.
Our own experience in the ATTEND trial 18 has shown the successful employment of 14 professional physiotherapists and 14 blinded assessors and clinical coordinators of varied health science background. Although not all of these employees had a previous formal training in research, the structured trial training and experience have empowered and motivated many of them to pursue a career in research, and contribute to research capacity development in India. Several of the principal investigators described securing additional funding through other research projects to maintain their trained clinical research staff after the completion of the ATTEND trial, and thus these staff could continue to drive local research and improve quality of care.
The current status of the ethics and regulatory systems also need to be considered, and some countries may need to establish an ethics framework before research should begin. Ensuring appropriate ethical conduct, as discussed in depth by Solbakk and Vidal, is essential and they point out the importance of a robust local ethics review. 3 Condo et al. 23 noted a key challenge for setting locally relevant clinical trial priorities for Rwanda was that local ethics and regulatory institutions lacked the local capacity and expertise to follow through the ethics, design, and integrity of clinical trials. 23 In our experience, during the implementation of the ATTEND trial, 18 the ethics and regulatory environment in India were suited to behavioral intervention trials but not for pharmaceutical trials, due to onerous requirements to compensate healthcare costs in drug trials (regulations that have now been changed to facilitate more drug trials in India). During the conduct of trial, additional ethical dilemmas may occur. For example, during the followup of patients and carers in the ATTEND trial, clinical trial staff described their ethical dilemma following up families who could not afford rehabilitation and were in financial strife.
For those wishing to begin clinical stroke research, one pathway is to understand the local stroke epidemiology by obtaining local ethics approval to collect and record patient details in a systematic manner in the form of case report forms. This can be accomplished by training nurses or other ward staff who will be in contact with the patient for a longer time than the neurologist. In this manner, the local context can be described and research priorities will emerge ( Figure 1 ). These data are also required for site surveys before commencing any industry-sponsored trials that can also help a local site begin and gain experience in research methods. Those in private practice can also collaborate with bigger institutes for large scale multicenter studies.
Research funding
High quality research requires sufficient funding which is a key challenge in resource limited settings. One solution is obtaining funding from international resources, but this potentially comes with its own challenges of ''whose priorities'' are the research actually addressing. 15, 21 For example, Condo et al. 23 described the risk of ''unequal partnerships'' and the risk of research not addressing local population needs when clinical trial priorities were set by in Rwanda by local representatives (e.g. Rwandan government, academics) and international agencies (e.g. pharmaceutical companies, non-governmental organizations) with greater funding. Ali et al. 21 described a challenge of conducting cancer research in India, with potential ethical concerns with multinationals conducting pharmaceutical trials in India in regards to the lack of informed consent and the exploitation of the poor and illiterate. Such challenges related to the leverage of international funding strongly reinforce the importance of locally driven research.
International funding bodies need to team with the local researchers to ensure that their research builds local research capacity and strengthens the local health systems. 19, 21, 23, 27 For example, Ali et al. 21 described their strategies in overcoming their challenges in 2005 due to the lack of clinical trial and regulatory
International Journal of Stroke, 13 (2) infrastructure (e.g. inexperience staff, no established standard operating procedures) as experienced by their INDOX (India and Oxford) cancer research network. Their strategies included the joint design and conduct of research by the principal investigators from Institute for Cancer Medicine in Oxford and leading cancer centers in India, tailoring of standard operating procedures, extensive monitoring of quality and good clinical practice at sites, dedication of site staff to help the ''time poor'' principal investigators in trial management and working closely with the Drug Controller General of India to obtain regulatory approval for their trial. In the ATTEND trial, 6 the initial negative perception by the regulatory authorities of the agenda by international collaborators and Australian funding agency (and thus the relevance of the research question) was a key barrier that had to be overcome. This was achieved through extensive discussions that outlined that the research was led, initiated and piloted by a local academic neurologist and the Indian Institute of Public Health, in collaboration with academics from UK and Australia. Moreover, the research addressed an issue of local priority, which was the lack of access to multidisciplinary rehabilitation, and was highly motivating for Indian health providers, principal investigators, patients, and carers. Improvement to clinical care due to the robust data collection and follow up and greater understanding of patient contextual factors was described by health providers. Thus, our findings highlight the need for transparency, early consultation and engagement of local health, ethics and research authorities, and value of international collaborative research in strengthening health systems in limited resource settings.
Our case study of the ATTEND collaboration also highlights the importance of discussion at international stroke conferences, and we would recommend that conference organizers provide future sessions with a ''research in low and middle-income countries'' session theme, including plenty of opportunity for panel and audience discussion (Box 2). ATTEND also provides a good example of international funding providing initial feasibility funding, followed by more substantive funding, that built local research capacity, and then led to further international funding, thus providing more long-term research sustainability. The ATTEND trial collaborated with 14 hospitals and academic centers across India with a mix of state and central government, private, and corporate institutions. The Indian government has now funded a large Indian Stroke Clinical Trial (INSTRUcT network) constituting 27 International Journal of Stroke, 13 (2) institutes across India which are empowered to implement and run trials while employing and training research staff. With the formation of the INSTRUcT, further research capacity growth, supported by successful global grant applications, promises a bright future, with new data likely to drive local health improvement, and contribute to global health. This illustrates the importance of engaging with policy makers in creating a research culture.
Conclusions
The solutions to the challenges of research in limited resource settings are interlinked and include research training, research design and leveraging access to global research funding. Many of our own examples were driven, in part, by informal discussions at international conferences, and taking opportunities as they arose. Collegiality, and collaboration ensures we discuss the great challenges that many face in limited resource settings, and between us, we have the resources to build further research capacity for the benefit of our global citizens.
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